Biocon reports 84% fall in Q2 consolidated net profit

31 Oct 2024 Evaluate

Biocon has reported results for second quarter ended September 30, 2024 (Q2FY25).

The company has reported 90.78% fall in its net profit at Rs 3.20 crore for the quarter ended September 30, 2024 as compared to Rs 34.70 crore for the same quarter in the previous year. However, total income of the company increased by 1.80% at Rs 598.90 crore for Q2FY25 as compared to Rs 588.30 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 84.31% fall in net profit at Rs 27.10 crore for Q2FY25 as compared to Rs 172.70 crore for the same quarter in the previous year. However, total income of the company increased by 0.07% at Rs 3622.90 crore for Q2FY25 as compared to Rs 3620.20 crore for the corresponding quarter previous year.

Biocon Share Price

335.95 -14.40 (-4.11%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.